Tapangan Pediatrics

Tapangan Pediatrics was paid $7.95M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.

33Billing provider infoTAPANGAN PEDIATRICS
SAN BENITO, TX 78586

33aNPI1942243951assigned 06/14/2006

33bProvider typePediatrics Physician

28Total paid$7.95M

24GClaims377,846

24DCodes billed75

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#38 of 1,136

Median peer was paid$329K

This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	538	$14K
2019	700	$13K
2020	27,532	$508K
2021	97,449	$1.96M
2022	100,235	$2.09M
2023	83,790	$1.82M
2024incomplete	67,602	$1.54M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	28%	63,149	56,325	$2.21M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	7.7%	8,322	7,970	$613K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	6.9%	7,083	6,816	$546K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	6.7%	12,909	11,980	$535K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	6.3%	12,542	11,506	$503K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	6.3%	37,923	17,756	$497K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	6.1%	6,217	5,734	$483K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	5.4%	5,986	5,573	$431K
90460	Immunization administration through 18 years of age via any route, first or only component	4.3%	33,053	14,788	$341K
S8301	Infection control supplies, not otherwise specified	4.1%	47,740	42,135	$329K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.8%	4,450	4,136	$222K
99429		2.8%	7,034	6,815	$221K

63 more codes

87428		2.6%	3,087	$205K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.5%	8,945	$119K
99203	Doctor's office visit, new patient (routine)	1.2%	1,679	$97K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.1%	3,703	$84K
87634		<1%	1,298	$75K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	7,354	$56K
90461		<1%	6,033	$41K
99000		<1%	3,941	$38K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,233	$37K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,710	$35K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,236	$33K
87807		<1%	2,297	$24K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	2,050	$19K
CP002		<1%	1,842	$18K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	427	$17K
99051		<1%	2,413	$15K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	161	$12K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	813	$12K
86318		<1%	720	$11K
96161		<1%	6,043	$11K
90473		<1%	1,281	$10K
92567		<1%	729	$9K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,438	$9K
81002		<1%	3,064	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	623	$7K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	487	$6K
90474		<1%	543	$4K
97169		<1%	162	$4K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	26	$2K
99050		<1%	114	$2K
96381		<1%	71	$1K
90619		<1%	1,138	$544.11
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	371	$540.33
81025		<1%	53	$368.73
90620		<1%	991	$256.20
86580		<1%	30	$247.56
90686		<1%	1,804	$86.69
90671		<1%	1,000	$82.00
90651		<1%	2,170	$78.00
86308		<1%	13	$56.55
97802		<1%	14,995	$15.50
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	16	$9.12
83655		<1%	341	$3.35
90670		<1%	3,650	$2.00
96160		<1%	1,183	$2.00
S9451	Exercise classes, non-physician provider, per session	<1%	15,024	$1.17
90677		<1%	16	$1.00
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	79	$0.50
90696		<1%	606	$0.35
90697		<1%	66	$0.35
90680		0%	2,590	$0.00
90723		0%	3,445	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	1,121	$0.00
90660		0%	3,271	$0.00
90656		0%	404	$0.00
90381		0%	56	$0.00
90648		0%	4,589	$0.00
90710		0%	2,158	$0.00
90700		0%	622	$0.00
90633		0%	2,237	$0.00
90715		0%	515	$0.00
90734		0%	349	$0.00
99072		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTAPANGAN, ROSELLER (OWNER)